BioCentury
ARTICLE | Clinical News

Epodure: Phase I/II started

August 4, 2008 7:00 AM UTC

Medgenics began a dose-ranging, Israeli Phase I/II trial to evaluate 20 Units of EPO/kg per day strength of Epodure in 30 patients. Higher strengths of 40 and 60 Units of EPO/kg per day will be evalua...